Skip to content
healthcare.dev
Get a free key

Cevimeline Hydrochloride

NDC 87063-180, Cevimeline Hydrochloride, capsule, from ASCLEMED USA INC..

Product NDC
87063-180
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203775
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEVIMELINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Package NDCNDC-11Package
87063-180-0187063018001100 CAPSULE in 1 BOTTLE (87063-180-01)
87063-180-308706301803030 CAPSULE in 1 BOTTLE (87063-180-30)
87063-180-608706301806060 CAPSULE in 1 BOTTLE (87063-180-60)
87063-180-908706301809090 CAPSULE in 1 BOTTLE (87063-180-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bcaaec18-4ee1-4cfd-84da-8fe3b8c54fc4

Use it

Look up 87063-180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.